Galmed Pharmaceuticals Ltd

NASDAQ:GLMD  
2.37
+0.13 (+5.80%)
Earnings Announcements

Galmed Pharmaceuticals Reports Q4 Loss Per Share $0.48

Published: 03/18/2021 11:18 GMT
Galmed Pharmaceuticals Ltd (GLMD) - Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results.
Q4 Loss per Share $0.48.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.